Highlands Oncology Group Dept of Highlands Oncology Grp — Fayetteville, Arkansas

Highlands Oncology Group Dept of Highlands Oncology Grp is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Highlands Oncology Group Dept of Highlands Oncology Grp has participated in 16 clinical trials.

Therapeutic areas: Multiple Myeloma, Metastatic Breast Cancer, HER2+ Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group Dept of Highlands Oncology Grp?

Highlands Oncology Group Dept of Highlands Oncology Grp has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group Dept of Highlands Oncology Grp conducted?

Highlands Oncology Group Dept of Highlands Oncology Grp has 16 clinical trials on record. Their work covers Multiple Myeloma, Metastatic Breast Cancer, HER2+ Breast Cancer.

Is Highlands Oncology Group Dept of Highlands Oncology Grp accredited by Crixeo Health?

Yes — Highlands Oncology Group Dept of Highlands Oncology Grp holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Highlands Oncology Group Dept of Highlands Oncology Grp?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.